Group 1 will receive 15 Hz
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Florida
Overview
Group 1 will receive 15 Hz is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Group 1 will receive 15 Hz clinical trials
Explore related
Medical disclaimer. This page summarizes research about Group 1 will receive 15 Hz for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.